Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that the Company will participate in the following virtual investor conferences in May and June 2021:


GlobeNewswire Inc | May 24, 2021 09:06AM EDT

May 24, 2021

BUFFALO, N.Y., May 24, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that the Company will participate in the following virtual investor conferences in May and June 2021:

-- On Wednesday, May 26, 2021, at 9:00 a.m. ET, the Company will host a fireside chat at the Stephens Food and Ag Disrupted Conference. -- On Thursday, June 3, 2021, at 9:50 a.m. ET, the Company will present at the Benzinga Cannabis Capital Conference. -- On Thursday, June 10, 2021, at 10:30 a.m. ET, the Company will be present at the 2021 LD Micro Invitational XI Conference.

The presentations and fireside chat will be webcast live from the Companys Investor Relations website under the Events subtab at: www.xxiicentury.com/investors/events.

Institutional investors and those invited to attend these virtual conference events may request one-on-one meetings with representatives of the Company, where offered, through the respective conference hosts or by contacting 22nd Century Groups investor relations via investorrelations@xxiicentury.com.

About 22nd Century Group, Inc.22nd Century Group, Inc. (NYSE American: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Centurys primary mission in tobacco is to reduce the harm caused by smoking through the Companys reduced nicotine content tobacco cigarettes containing 95% less nicotine than conventional cigarettes. The Companys primary mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits.

Learn more at xxiicentury.com, on Twitter @_xxiicentury, and on LinkedIn.

Investor Relations & Media Contact:Mei KuoDirector, Communications & Investor Relations22nd Century Group, Inc.(716) 300-1221mkuo@xxiicentury.com







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC